Nuzenio

Catalent Fda

Catalent Fda news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Novo’s Catalent plant ditched in FDA refiling of SMA drug - Fierce PharmaFierce Pharma · Mon, 10 Aug 2026 14:06:15 GMTScholar Rock shifts apitegromab BLA to second fill-finish site after Catalent FDA inspection - AllSciAllSci · Mon, 10 Aug 2026 10:21:59 GMTScholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date - BioSpaceBioSpace · Mon, 10 Aug 2026 02:16:42 GMTScholar Rock drops Catalent facility from marketing application for muscle weakness drug - 1470 & 100.3 WMBD1470 & 100.3 WMBD · Sat, 08 Aug 2026 02:32:33 GMT

Timeline

Mon, 10 Aug 2026 14:06:15 GMTNovo’s Catalent plant ditched in FDA refiling of SMA drug - Fierce Pharma
Mon, 10 Aug 2026 10:21:59 GMTScholar Rock shifts apitegromab BLA to second fill-finish site after Catalent FDA inspection - AllSci
Mon, 10 Aug 2026 02:16:42 GMTScholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date - BioSpace
Sat, 08 Aug 2026 02:32:33 GMTScholar Rock drops Catalent facility from marketing application for muscle weakness drug - 1470 & 100.3 WMBD

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Catalent Fda.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.